| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | , 2007  Vol. 25  No.3 Previous Issue | Next Issue | Archive
In this issue:


Original Articles
Impact of Cyclooxygenase-2 Expression on the Survival of Glioblastoma
Youngmin Choi, Dae Cheol Kim, Ki Uk Kim, Young Jin Song, Hyung Sik Lee, Won Joo Hur, Sun Seob Choi, Su Yeong Seo
Radiat Oncol J. 2007;25(3):145-150.
PURPOSE: To investigate the degree and effect of cyclooxygenase (COX)-2 expression on the survival of patients with glioblastoma multiforme (GM). MATERIALS AND METHODS: Between 1997 and 2006, thirty consecutive GM patients treated with surgery and postoperative radiotherapy (dose range: 44~65.1 Gy, median dose: 61.2 Gy) were included in the study. Three patients were excluded that discontinued radiotherapy before receiving a dose...
Treatments Results and Prognostic Factors in Locally Advanced Hypopharyngeal Cancer
Mee Sun Yoon, Woong Ki Chung, Sung Ja Ahn, Taek Keun Nam, Ju Young Song, Byung Sik Nah, Sang Cheol Lim, Joon Kyoo Lee
Radiat Oncol J. 2007;25(3):151-159.
PURPOSE: The purpose of this study is to present the treatment results and to identify possible prognostic indicators in patients with locally advanced hypopharyngeal carcinoma. MATERIALS AND METHODS: Between October 1985 to December 2000, 90 patients who had locally advanced stage IV hypopharyngeal carcinoma were studied retrospectively. Twelve patients were treated with radiotherapy alone, 65 patients were treated with a combination of...
Preoperative Concurrent Radiochemotherapy for Locally Advanced Esophageal Cancer: Treatment Outcome and Prognostic Factors
Haeyoung Kim, Yong Chan Ahn, Kwan Min Kim, Jhingook Kim, Young Mog Shim, Young Hyuck Im
Radiat Oncol J. 2007;25(3):160-169.
PURPOSE: This study reports the results of the use of preoperative concurrent radiochemotherapy (CRCT) for the treatment of locoregionally advanced esophageal cancer. MATERIALS AND METHODS: From 1998 through 2005, 61 patients with intrathoracic esophageal cancer at stages II-IVB (without distant organ metastasis and presumed to be respectable) received preoperative CRCT. CRCT consisted of radiotherapy (45 Gy /25 fractions /5 weeks) and...
The Role of Radiotherapy in the Treatment of Portal Vein Thrombosis from Advanced Hepatocellular Carcinoma
Jung Hoon Kim, Eun Kyung Choi, Seung Do Ahn, Sang Wook Lee, Seong Soo Shin, Wonsik Choi, Young Suk Lim, Kang Mo Kim, Dong Jin Suh, Young Wha Chung, Young Sang Lee, Hyung Jin Won, Jong Hoon Kim
Radiat Oncol J. 2007;25(3):170-176.
PURPOSE: To determine the role of radiotherapy for the treatment of portal vein thrombosis (PVT) from hepatocellular carcinoma (HCC). MATERIAL AND METHODS: A retrospective analysis was performed on 70 patients that had been diagnosed with HCC and were treated with three-dimensional conformal radiotherapy (3D-CRT) for the PVT. The radiation dose ranged from 40 Gy to 60 Gy (median dose: 48 Gy)...
The Palliative Effect of Endobronchial Brachytherapy for Previously Irradiated Patients with Lung Cancer
Young Je Park, Chul Yong Kim, Kwang Taik Kim, Dae Sik Yang, Suk Lee
Radiat Oncol J. 2007;25(3):177-184.
PURPOSE: To evaluate the palliative effect of endobronchial brachytherapy (EBB) for patients with lung cancer that previously received external beam radiotherapy (EBRT). MATERIALS AND METHODS: From July 1992 to May 2003, 29 patients with a recurrent or persistent lung cancer were treated with palliative EBB at our institute. EBB consisted of three fractions (once a week) of a dose of 5...
Immune Cell Activation and Co-X-irradiation Effect of Eleutherococcus senticosus Maxim Root
Hyoung Cheol Kwon, Jeong Seob Park, Dong Seong Choi
Radiat Oncol J. 2007;25(3):185-191.
PURPOSE: This study was performed to investigate the effects of immune cell activation and the antitumor effect for the combination of treatment with X-irradiation and Eleutherococcus senticosus Maxim Root (ESMR) on mouse tumor cells. MATERIALS AND METHODS: ESMR (250g) was extracted with 80% methanol, concentrated under decompression and lyophilized. To determine whether ESMR is able to activate the immune cells or not,...
Published Erratum
Erratum
Jin Oh Kang
Radiat Oncol J. 2007;25(3):192-192.
No abstract available.
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 1.8
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Elekta Korea
DAWON MEDAX
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next